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Autophagy, a catabolic process involving intracellular degradation of
unnecessary or dysfunctional cellular components through the
lysosomal machinery, could act as a prosurvival, as well as a cyto-
toxic mechanism (Parzych and Klionsky, 2014) [1]. Cyclooxygenase
inhibitor indomethacin inhibits proliferation of glioma cells, and
has been reported to reduce the activity of the main autop-
hagy repressor mammalian target of rapamycin (mTOR)
(Pantovic et al., 2016) [2]. Here we investigated the ability of indo-
methacin to induce autophagy in U251 human glioma cells. We
assessed the influence of indomethacin on intracellular acidifica-
tion, expression of proautophagic protein beclin-1, and conversion
of microtubule-associated protein light chain 3-I (LC3-I) to
autophagosome-associated LC3-II, in the presence or absence of
lysosomal inhibitors. The effect of genetic and pharmacologi-
cal downregulation of autophagy on the cytotoxicity of indo-
methacinwas also evaluated. The interpretation of these data can be
found in “In vitro antiglioma action of indomethacin is mediated
via AMP-activated protein kinase/mTOR complex 1 signaling path-
way” (Pantovic et al., 2016; http://dx.doi.org/10.1016/j.biocel.2016.vier Inc. This is an open access article under the CC BY license
/j.biocel.2016.12.007
rajkovic), buajk@yahoo.com (L. Harhaji-Trajkovic).
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(http://creativecommons.org/licenses/by/4.0/).Specifications Tableubject area Biology
ore specific
subject areaGlioma, autophagy, indomethacinype of data Figure
ow data was
acquiredFlow cytometry, immunoblot, siRNA transfection, and MTT viability testata format Analyzed
xperimental
factorsU251 glioma cells were treated with indomethacin and bafilomycin A1, chlor-
oquine, wortmannin, or ammonium chloride, or transfected with LC3, beclin-1, or
control siRNA before treatment with indomethacinxperimental
featuresAfter indomethacin treatment viability of U251 cells was determined, or the cells
were prepared for the flow cytometric and immunoblot assessment of autophagy
markersata source
locationSchool of Medicine, Belgrade, Serbiaata accessibility All data are provided with this articleDValue of the data
 The data provide the assessment of autophagy-inducing ability of indomethacin in glioma cells.
 The data provide the assessment of the effect of pharmacological and genetic inhibition of
autophagy on the cytotoxic action of indomethacin.
 These data might be valuable for researchers interested in autophagy-modulating effects of
cyclooxygenase inhibitors.
 These data might be valuable for researchers interested in anticancer and antiglioma effects of
indomethacin.1. Data
To investigate the ability of indomethacin to induce autophagy in U251 glioma cells, we assessed
its influence on intracellular acidification, expression of beclin-1, and conversion of microtubule-
associated protein light chain 3 (LC3) as autophagy hallmarks [1]. Flow cytometric analysis of pH-
sensitive acridine orange fluorescence revealed that indomethacin failed to increase intracellular
acidification (Fig. 1A). Furthermore, the drug did not increase the expression of proautophagic protein
beclin-1 or conversion of LC3-I to its lipidated, autophagosome-associated LC3-II form (Fig. 1B). Since
the inability of indomethacin to augment LC3-II levels could result from the increase in LC3 degra-
dation in autophagolysosomes [3], we analyzed LC3-II concentration in cells in which autophagic
proteolysis was blocked by lysosomal inhibitors chloroquine, bafilomycin A1, or ammonium chloride.
While proteolysis inhibitors expectedly increased the levels of LC3-II when applied alone, no addi-
tional increase was detected in the presence of indomethacin (Fig. 1C), thus confirming its inability to
increase autophagic flux. We next employed genetic and pharmacological approaches to assess the
role of autophagy in indomethacin-mediated cytotoxicity to U251 cells [2]. RNA interference-
Fig. 1. The effect of indomethacin on the expression of autophagy markers in U251 glioma cells. (A) U251 cells were incubated
with indomethacin (250 mM) for 24 h. The intracellular acidification was determined by flow cytometry as a ratio of acridine
orange (AO) red/green (FL3/FL1) mean fluorescence intensity, and the representative flow cytometry histograms of three
independent experiments are shown. (B) U251 cells were incubated with indomethacin (250 mM) for the indicated time
periods, and beclin-1 and LC3 levels were analyzed by immunoblotting. (C) Autophagic flux was assessed by examining LC3
conversion in U251 cells incubated with indomethacin (250 mM) for 8 h, in the presence or absence or proteolysis inhibitors
chloroquine (CQ; 20 mM), ammonium chloride (AC; 20 mM), or bafilomycin A1 (BAF; 20 nm). (B, C) The representative blots are
shown, and the data are presented as mean7SD values of three independent experiments (*po0.05 compared to untreated
cells).
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confirmed by immunoblot in Fig. 2A) had no effect on the viability of indomethacin-treated U251 cells
(Fig. 2B). Accordingly, the suppression of autophagy by proton-pump blocker bafilomycin A1, lyso-
somal inhibitor chloroquine, or class III phosphoinositide 3-kinase inhibitor wortmannin [3] failed to
affect antiglioma effect of indomethacin (Fig. 2C).2. Experimental design, materials and methods
2.1. Cells and cell culture
The human glioma cell line U251-MG was obtained from the European Collection of Authenticated
Cell Cultures (ECACC 09063001), and maintained in 20 mM HEPES (4-(2-hydroxyethyl)-1-piper-
azineethanesulfonic acid)-buffered Roswell Park Memorial Institute (RPMI) 1640 cell culture medium
supplemented with 2 mM L-glutamine, antibiotic/antimycotic mixture (1%), and 10% fetal bovine
serum (all from PAA, Pasching, Austria). U251 glioma cells before passage 10 were incubated in 96-
well flat bottom plates (1104 cells/well) for the cell viability assays, 24-well plates (1105 cells/
Fig. 2. The effect of genetic and pharmacological inhibition of autophagy on indomethacin cytotoxicity. (A, B) U251 cells were
transfected with control, beclin (BCN1), or LC3 siRNA. The knockdown efficiency was assessed by immunoblot (A). The siRNA-
transfected cells were incubated with different concentrations of indomethacin for 24 h, and the cell viability was assessed by
MTT assay (B). (C) U251 cells were treated for 24 h with indomethacin (250 mM) in the presence or absence of autophagy
inhibitors bafilomycin A1 (BAF; 20 nM), chloroquine (CQ; 20 mM), or wortmannin (WORT; 200 nM), and cell viability was
analyzed by MTT assay. (A-C) The data are presented as mean7SD values of at least three independent experiments
(*po0.05).
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Cells were rested for 24 h and then treated with indomethacin (Sigma-Aldrich, St. Louis, MO) in the
presence or absence of bafilomycin A1, chloroquine, ammonium chloride, or wortmannin (all from
Sigma-Aldrich, St. Louis, MO). The incubation times and concentrations of agents are stated in figure
captions and/or figures.
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The cell viability was determined exactly as previously described, using MTT (3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay to measure the activity of mitochondrial
dehydrogenases [4]. The results were presented as % of the cell viability in untreated cells.2.3. Intracellular acidification measurement
The changes in intracellular acidification were assessed by supravital staining with acridine orange
(Sigma-Aldrich, St. Louis, MO), a pH-sensitive dye that shifts its fluorescence from green to red with
decreasing pH. Acridine orange-stained cells (1 mM, 15 min, 37 °C) were analyzed using FACSCalibur
flow cytometer (BD Biosciences, Heidelberg, Germany) and CellQuest Pro software, and intracellular
acidification was quantified as a red/green fluorescence ratio (mean FL3/FL1), arbitrarily set to 1 in
control samples.2.4. Immunoblotting
Cells were lysed by 30 min incubation on ice in lysis buffer (30 mM Tris–HCl pH 8.0, 150 mM NaCl,
1% NP-40) containing protease/phosphatase inhibitor cocktail (all from Sigma-Aldrich, St. Louis, MO).
The cell lysates were centrifuged at 14000 g for 15 min at 4 °C, and the supernatants were collected.
Equal protein amounts from each sample were separated by SDS-PAGE and transferred to nitro-
cellulose membranes (Bio-Rad, Marnes-la-Coquette, France). Following incubation with rabbit anti-
bodies against LC3B, beclin-1, and actin (all from Cell Signaling Technology, Beverly, MA) as primary
antibodies, and peroxidase-conjugated goat anti-rabbit IgG (Jackson IP Laboratories, West Grove, PA)
as a secondary antibody, specific protein bands were visualized using enhanced chemiluminescence
reagents (Amersham Pharmacia Biotech, Piscataway, NJ). The protein levels were quantified by
densitometry using ImageJ software (NIH, Bethesda, MD), and expressed relative to actin as a loading
control. The results are presented as fold change in signal intensity, which was arbitrarily set to 1 in
untreated cells.2.5. RNA interference
The transfection of subconfluent U251 cells with small interfering RNA (siRNA) targeting human
beclin-1, LC3B, or scrambled control siRNA (FlexiTube GeneSolution with 4 preselected siRNAs for
each gene; Qiagen, Valencia, CA) was performed using Lipofectamine (Invitrogen, Carlsbad, CA)
according to the manufacturer's instructions. After transfection, cells were grown for 24 h before
treatment with indomethacin.2.6. Statistical analysis
The statistical significance of the differences was analyzed by one-way analysis of variance
(ANOVA) followed by Student-Newman–Keuls test. A p value of less than 0.05 was considered sig-
nificant. Each experiment was performed in triplicates and the data are presented as mean7SD from
at least three independent experiments.Acknowledgments
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